The exaggerated fear of AI annihilation, while dismissed by practitioners, has shaped US policy. This risk-averse climate discourages domestic open-source model releases, creating a vacuum that more permissive nations are filling and leading to a strategic dependency on their models.

Leading AI labs are strategically releasing high-risk capabilities, like cybersecurity exploits, to trusted defenders before a general public release. This pattern, seen with Anthropic and OpenAI, aims to harden systems against potential misuse, with biosafety likely being the next frontier for this approach.

The argument for rapidly advancing powerful AI is that only the leading labs can influence safety protocols. This 'stay in the lead to steer' philosophy creates a paradox: to mitigate AI risk, companies feel compelled to accelerate its development, potentially amplifying the very dangers they aim to control.

As the capability gap between internal and public models widens, the most critical decisions about safety will be made pre-release. This internal frontier lacks a governance framework, as current regulations are only triggered by public deployment.

A pause on training new, more capable AI models could paradoxically increase risk. It would halt progress at the few, relatively safety-conscious frontier labs, allowing less scrupulous competitors to catch up. Meanwhile, compute stockpiling would continue, making any subsequent capability leap even faster and more dangerous.

The decision to restrict powerful but dangerous AI models like Claude Mythos to a select group of large corporations for safety reasons risks creating a massive centralization of power. This gives these entities an insurmountable technological advantage over smaller players and the public.

New AI capabilities are not released to everyone at once. There's a "gas chromatograph" effect where access is staggered: first to internal lab researchers, then governments, then high-paying enterprise customers, then premium subscribers, and finally free users. This creates a significant time-lag and power differential based on status and payment.

A new executive order proposes a 90-day government review period before new AI models can be released. This lengthy delay poses a significant threat to the AI industry's core competitive advantage: its breakneck speed of innovation and iteration. Such a slowdown could fundamentally alter the release cadence and competitive dynamics among the major labs.

Self-imposed safety pauses and regulatory hurdles on US frontier models create a vacuum. Chinese open-weight models like GLM-5.2 are now as capable as the *currently available* US versions, eroding the American lead while its most advanced models are benched, effectively ceding ground in the global AI race.